期刊文献+

肌松闭环注射系统在全身麻醉中的应用 被引量:8

Research the close-loop muscle relaxant injection system in general anesthesia
下载PDF
导出
摘要 目的:研究闭环肌松注射系统用于全身麻醉的临床效果及安全性。方法:随机选择180例择期全身麻醉患者,ASAI-II级,随机分为两组:闭环肌松注射系统组(C组);E组(E组)。每组90例,C组采用闭环肌松注射系统给予肌松药,E采用麻醉医师临床经验判断给予肌松药。在入室、诱导即刻、插管、切皮、进腹、探查、关腹、缝皮、意识恢复、气管拨管、出室11个时间点(T1~T11),观察记录各项生命指标;记录肌松药总量、诱导苏醒时间、Copper评级、术中体动反应率、麻醉医师满意率及手术医师满意率;记录不良反应。结果:两组一般资料比较、T1-T7各时点生命体征比较无统计学意义(P>0.05)。与E组比较,C组缝皮、意识恢复、气管拨管、出室各时间点呼吸频率及脉搏氧饱和度均升高(P<0.05);C组肌松计数、TOF值在T3-T8时较低(P<0.05),T9-T11时较高(P<0.05);C组插管时间、肌松药总量、拮抗剂用量、诱导苏醒时间均降低(P<0.05);C组Copper评级、麻醉医生满意率、手术医生满意率均升高(P<0.05),术中体动反应率降低(P<0.05);C组术后呼吸抑制、呕吐均降低(P<0.05)。结论:闭环肌松注射系统用于全身麻醉,可以减少肌松药的用量和不良反应,手术麻醉中肌松强度可控性强,术后麻醉苏醒及时。 Objective:To study of closed-loop muscle relaxant injection system(CLMRIS) the clinical efficacy and safety for general anesthesia.Methods:180 cases of randomly selected elective general anesthesia patients,ASA I-II,were randomly divided into two groups:CLMRIS the treatment group(C group);experience in treatment group(E group).Results:Each group of 90 cases,C using the CLMRIS for muscle relaxants,E used to determine clinical experience of anesthesiologists to give muscle relaxants.Respectively,burglary,induced immediately,intubation,skin incision,into the abdomen,exploration,offbellied,sewing skin,awareness of recovery,tracheal tube dial,out of room in 11 time points(T1~T11),observed and recorded MAP,HR,RR,SpO2,muscle relaxants count,TOFR;record of the total muscle relaxants to induce recovery time,Copper ratings,intraoperative body movement response rate,anesthesiologist and surgeon satisfaction rate of satisfaction;record of adverse drug reactions.Conclusion:CLMRIS for general anesthesia,muscle relaxation can reduce drug usage and adverse reactions,muscle relaxant anesthesia intensity control,and postoperative recovery from anesthesia time.
出处 《临床医药实践》 2010年第7X期820-823,共4页 Proceeding of Clinical Medicine
基金 陕西省宝鸡市卫生局科研基金资助项目 编号:2009-01<全身麻醉量化管理>
关键词 闭环肌松注射系统 肌松药 全身麻醉 Close-Loop Muscle Relaxant Injection System Muscle relaxants general anesthesia
  • 相关文献

参考文献4

二级参考文献63

  • 1Gal TJ, Goldberg SK. Relationship between respiratory muscle strength and vital capacity during partial curarization in awake subjects. Anesthesiol,1981,54:141-147.
  • 2Cooper AL, Leigh JM, Tring IC. Admission to the intensive care unit after complications of anaesthetic techniques over 10 years. Anaethesia, 1989,44: 953-958.
  • 3Baydur A, Cha EJ, Sassoon. Validation of esophageal balloon technique at different lung volumes and postures. J Appl Physiol, 1987,62:315-321.
  • 4Fezing AK, d'Hollander A, Boogaerts JG. Assessment of the postoperative residual curarisation using the train of four stimulation with acceleromyography. Acta Anaesthesiol Belg, 1999,50:83-86.
  • 5Gatke M.R, Viby-Mogensen J, Rosenstock C, et al. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyograph is used. Acta Anaesthesiol Scand,2002,46:207-213.
  • 6Dupuis JY, Martin R, Tetrault JP. Clinical, electrical and mechanical correlations during recovery from neuromuscular blockade with vecuronium. CanJ Anaesth,1990,37:192-196.
  • 7Hayes AH, Mirakhur RK, Breslin DS, et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia,2001,56: 312-318.
  • 8Cammu G, de-Baerdemaeker L, den-Blauwen N, et al. Postoperative residual curarization with cisatracurium and rocuronium infusions. Eur J Anesth, 2002,19:129-134.
  • 9Kopman AF, Yee PS, Neuman G. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiol, 1997,86:765-771.
  • 10Brull SJ. Indicators of recovery of neuromuscular function: time for change? Anesthesiology, 1997,86: 755-757.

共引文献27

同被引文献77

  • 1闻大翔,杭燕南.肌松药残余阻滞作用与呼吸功能恢复[J].国外医学(麻醉学与复苏分册),2004,25(4):234-236. 被引量:21
  • 2周俊,杨智慧,李恒,杨承祥.阿曲库铵靶控静脉输注的临床效果[J].广东医学,2005,26(2):223-224. 被引量:4
  • 3邓晓倩,朱涛,魏新川.困难气道及其预测[J].国际麻醉学与复苏杂志,2006,27(6):351-353. 被引量:19
  • 4Khuenl-Brady KS, Sparr H. Clinical pharmacokinetics of rocuronium bromide [ J ]. Clin Pharmacokinet, 1996, 31 :174 -183.
  • 5Khalil M, D'Honneur G, Duvaldestin P, et al. Pharrnacoki-netics and pharmacodynamics of rocuronium in patients with cirrhosis[ J]. Anesthesiology, 1994, 80:1241 - 1247.
  • 6Hunter JM. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis[J]. Eur J Anaesthesiol Suppl, 1995, 11: 39 -41.
  • 7Miller RD, TA Ward. Monitoring and pharmacologic rever- sal of a nondepolarizing neuromuscular blockade should be routine[J]. Anesth Analg, 2010, 111 : 3 -5.
  • 8Illman H, Antila H, Olkkola KT. Quantitation of the effect of nitrous oxide on rocuronium infusion requirements using closed-loop feedback control [ J ]. Anesthesiology, 2008, 108:388 - 391.
  • 9Eleveld D J, Proost JH, Wierda JM. Evaluation of a closed- loop muscle relaxation control system [ J]. AnesthAnalg, 2005, 101:758 -764.
  • 10Vanacker BF, Vermeyen KM, Struys MM, et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane[ J ]. Anesth Analg, 2007, 104:563-568.

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部